Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2017

Feb 21, 2017

31949_dirs_2017-02-21_79554c6a-0b9c-4613-8ce6-ee58c1fa25d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-01-03

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 18923393 Indirect
Ordinary Shares 82671 Direct

Footnotes

F1: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

F2: This Form 4/A amends the Form 4 filed on January 4, 2017 to accurately reflect the securities reported in Table I, Column 5, Rows 1 and 2. All other information contained in the original Form 4 was accurately reported.